This is probably CVS partnering in paying for an expansion in manufacturing capacity (or promising to make some payments if they don't meet some sales goals) and is really a drop from $150 (the previous price point of generic Adrenaclick). I wouldn't count on further drops in price, at least not without other generics coming to market.
And at this rate it only takes a couple more iterations of competition until the thing is almost free.
Excellent, I say.